Oscar Health (OSCR) Return on Sales (2020 - 2026)

Oscar Health has reported Return on Sales for 7 years, with the latest figure at 1.19% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales rose 55.0% year-over-year to 1.19%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales for Q1 2026 stood at 1.19%, up from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 1.19% in Q1 2026, with the low at 0.16% in Q3 2025.
• Historically, Return on Sales has averaged 0.09% across 5 years, with a median of 0.0% in 2024.
• Annual changes were most pronounced in 2022 — Return on Sales jumped 296 bps — and 2024, when it fell 11 bps.
• Oscar Health's Return on Sales stood at 0.0% in 2022, then soared by 58 bps to 0.0% in 2023, then soared by 37 bps to 0.0% in 2024, then surged by 50 bps to 0.0% in 2025, then surged by 393716 bps to 1.19% in 2026.
• The last three Return on Sales figures came in at 1.19% (Q1 2026), 0.0% (Q4 2025), and 0.16% (Q3 2025), per Business Quant data.